The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...

Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge and trigger a new outbreak years later. How do they survive? And how can ...

MT-125, a dual small-molecule inhibitor, received FDA fast track designation for glioblastoma, facilitating expedited drug ...

Roche has dropped five Chugai candidates from its clinical pipeline, echoing actions the Japanese business took earlier this ...

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most ...

What if you could taste an early flu infection? Chemists report a molecular sensor that, when placed on an infected tongue as a thin film or gum, will release thyme’s main flavor compound, thymol (ACS ...

Beijing Advanced Innovation Center for Soft Matter Science and Engineering and State Key Laboratory of Organic−Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, People’s ...

Scientists have uncovered a breakthrough way to stop type 2 diabetes and fatty liver disease—right at the source. A harmful molecule produced by gut bacteria, called D-lactate, has been found to ...

Researchers have designed a peptide that prevents the deadly misfolding of alpha-synuclein, the protein behind Parkinson’s and some dementias. In lab and animal tests, it stabilized the protein and ...

Peter Marks, M.D., Ph.D., the former head of the FDA’s Center for Biologics Evaluation and Research (CBER), has joined Eli Lilly as senior vice president of molecule discovery and head of infectious ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Peter Marks, the ...